WVU Medicine Deploys AI-Powered Stroke Imaging Across Entire Network, Bridging the Care Gap
Morgantown, WV – In a landmark move to standardize and accelerate stroke care, West Virginia University (WVU) Medicine has fully integrated Brainomix 360 Stroke, an advanced artificial intelligence imaging platform, across all 25 of its hospital locations. This widespread deployment promises to dramatically improve outcomes for stroke patients, regardless of their initial point of care, and represents a significant step forward in addressing healthcare disparities in the region.
The Brainomix platform utilizes sophisticated algorithms to analyze critical imaging modalities – including CT, CTA, CTP, and MRI – in real-time. This rapid analysis provides clinicians with objective data regarding large-vessel occlusions (LVOs) and precise ischemic core volume measurements, crucial factors in determining the most effective treatment pathway and the necessity for rapid transfer to comprehensive stroke centers.
The Challenge of Equitable Stroke Care
Historically, access to specialized stroke care has been unevenly distributed, particularly in rural areas. Smaller community hospitals often rely on on-call radiologists, whose expertise in complex neurovascular imaging may vary. This inconsistency can lead to delays in diagnosis, missed opportunities for timely intervention, and ultimately, poorer patient outcomes. The time-sensitive nature of stroke treatment – where “time is brain” – underscores the critical need for rapid, accurate assessment.
Brainomix 360 Stroke effectively eliminates this variability. By automating the initial imaging analysis, the platform delivers a consistent, expert-level assessment to every patient, irrespective of their location within the WVU Medicine network. This standardization ensures that patients arriving at a rural facility receive the same level of diagnostic scrutiny as those presenting at WVU’s flagship academic medical center.
How Brainomix 360 Stroke Works
The platform seamlessly integrates into existing hospital workflows, ingesting imaging scans and applying FDA-cleared algorithms to swiftly identify potential LVOs, calculate ASPECTS scores (a standardized measure of early ischemic changes), and estimate the size of the ischemic core – the area of brain tissue already irreversibly damaged by stroke. This information is immediately available to clinicians, enabling faster, more informed decisions regarding treatment options, including mechanical thrombectomy, a life-saving procedure to remove blood clots from the brain.
“WVU Medicine is committed to advancing patient care through technologies that support clinical decision making and improve the patient experience,” stated Charles J. Barkey, Vice President of Information Technology for Northern Panhandle WVU Medicine Hospitals. “As part of this effort, we recently implemented Brainomix’s AI imaging platform across our network to help reduce time to treatment for potentially critical stroke types.”
Did You Know?:
Beyond the Scan: Enterprise-Level Benefits
The benefits of Brainomix extend beyond the immediate clinical impact. For a large, integrated health system like WVU Medicine, the platform streamlines operations, reduces administrative burden, and optimizes revenue cycle management. Fragmented imaging workflows, common in hub-and-spoke hospital networks, often result in delayed patient transfers, disjointed electronic health record (EHR) documentation, and inaccurate acuity capture.
By deploying Brainomix across all 25 sites, WVU Medicine is creating a unified, standardized imaging ecosystem. The AI-powered platform complements existing telestroke services, ensuring that receiving comprehensive stroke centers have immediate access to highly accurate diagnostic data upon patient arrival. This seamless data flow reduces administrative overhead, facilitates accurate coding, and ultimately maximizes the health system’s ability to deliver high-value, high-acuity care. What impact do you think standardized AI-driven diagnostics will have on the future of rural healthcare access?
Brainomix, originally a spin-out from the University of Oxford, has been rapidly expanding its presence in the U.S. market, driven by the growing recognition of the platform’s clinical and operational value. The company’s commitment to innovation and its focus on improving stroke care are positioning it as a leader in the field of AI-powered medical imaging. Could this technology be adapted for other time-sensitive conditions, such as traumatic brain injury?
Learn more about Brainomix 360 Stroke and explore WVU Medicine’s comprehensive stroke care services.
Frequently Asked Questions About Brainomix 360 Stroke
What is Brainomix 360 Stroke and how does it improve stroke diagnosis?
Brainomix 360 Stroke is an AI-powered imaging platform that analyzes CT, CTA, CTP, and MRI scans in real-time to identify critical indicators of stroke, such as large-vessel occlusions and ischemic core volume, leading to faster and more accurate diagnoses.
How does the Brainomix platform address disparities in stroke care access?
By providing a standardized, AI-driven assessment to all patients, regardless of their location, Brainomix 360 Stroke ensures that individuals in rural or underserved areas receive the same level of expert diagnostic evaluation as those in major medical centers.
What are the benefits of using AI in stroke imaging analysis?
AI in stroke imaging analysis offers several benefits, including increased speed, improved accuracy, reduced variability in interpretation, and the ability to identify subtle indicators that might be missed by the human eye.
How does Brainomix 360 Stroke integrate with existing hospital workflows?
The platform is designed to seamlessly integrate into existing hospital systems, ingesting imaging scans and providing results directly to clinicians within their familiar workflow environment.
What is the impact of Brainomix on mechanical thrombectomy rates?
Clinical studies have shown that implementing Brainomix 360 Stroke can increase mechanical thrombectomy rates by over 50%, significantly improving patient outcomes and functional independence.
What types of stroke imaging does the Brainomix platform analyze?
Brainomix 360 Stroke analyzes a comprehensive range of stroke imaging modalities, including non-contrast CT (NCCT), CT angiography (CTA), CT perfusion (CTP), and MRI.
Disclaimer: This article provides general information and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
Share this article to help raise awareness about the advancements in stroke care! What are your thoughts on the role of AI in transforming healthcare delivery?
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
